Skip to main content
Top
Published in: Comparative Clinical Pathology 4/2017

01-07-2017 | Original Article

Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice

Authors: Omar M. E. Abdel-Salam, Marwa El-Sayed El-Shamarka

Published in: Comparative Clinical Pathology | Issue 4/2017

Login to get access

Abstract

We examined the effect of the KATP channel opener nicorandil and the KATP channel blocker glibenclamide on the behavioral and biochemical responses to ketamine in mice. Ketamine was injected at 30 mg/kg intraperitoneally (i.p.) daily for 2 weeks, and mice were then treated with either saline, glibenclamide (5 mg/kg), nicorandil (1 or 5 mg/kg), sucrose 1 g/kg, or glibenclamide + sucrose 1 g/kg, i.p. daily for another 8 days. The control group received only saline. Data indicated that (i) ketamine increased locomotion, rearing, and grooming behaviors. Locomotor activity increased in the center while rearing activity increased in the periphery and center of the open field. Social interaction was markedly decreased by ketamine. Nicorandil at 1 mg/kg increased and at 5 mg/kg produced marked depression in ambulation in the center of the field and in rearing in the field periphery. Locomotor activity and rearing of ketamine-treated mice were not affected by glibenclamide. Meanwhile, either agent reversed the increase in grooming and the inhibition of social interaction caused by ketamine. Sucrose had no significant effect on grooming or social interaction of mice given ketamine but increased ambulation and rearing activity in the field center. (ii) Ketamine caused a significantly elevated brain lipid peroxidation (malondialdehyde) while decreasing reduced glutathione, nitric oxide, and paraoxonase-1 activity. These biochemical alterations were markedly alleviated by nicorandil or glibenclamide. The study suggests a potential therapeutic value for the KATP channel opener nicorandil in the ketamine model of schizophrenia.
Literature
go back to reference Abdel-Salam OME, Youness ER, Mohammed NA, Omara EA, Sleem AA (2015a) Effect of ketamine on oxidative stress following lipopolysaccharide administration. Comp Clin Pathol 24:53–63CrossRef Abdel-Salam OME, Youness ER, Mohammed NA, Omara EA, Sleem AA (2015a) Effect of ketamine on oxidative stress following lipopolysaccharide administration. Comp Clin Pathol 24:53–63CrossRef
go back to reference Abdel-Salam OME, Youness ER, Mohammed NA, Abu Elhamed WA (2015b) Nuclear factor-kappa B and other oxidative stress biomarkers in serum of autistic children. Open J Mol Integr Physiol 5:18–27CrossRef Abdel-Salam OME, Youness ER, Mohammed NA, Abu Elhamed WA (2015b) Nuclear factor-kappa B and other oxidative stress biomarkers in serum of autistic children. Open J Mol Integr Physiol 5:18–27CrossRef
go back to reference Ahern TL, Herring AA, Anderson ES, Madia VA, Fahimi J, Frazee BW (2015) The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med 33(2):197–201PubMedCrossRef Ahern TL, Herring AA, Anderson ES, Madia VA, Fahimi J, Frazee BW (2015) The first 500: initial experience with widespread use of low-dose ketamine for acute pain management in the ED. Am J Emerg Med 33(2):197–201PubMedCrossRef
go back to reference Arruda MOV, Soares PM, Honório JER, Lima RCS, Chaves EMC, Lobato RFG, Martin ALAR, Sales GTM, Carvalho KM, Assreuy AMS, de Brito EM, Vasconcelos SMM (2008) Activities of the antipsychotic drugs haloperidol and risperidone on behavioural effects induced by ketamine in mice. Sci Pharm 76(4):673–687CrossRef Arruda MOV, Soares PM, Honório JER, Lima RCS, Chaves EMC, Lobato RFG, Martin ALAR, Sales GTM, Carvalho KM, Assreuy AMS, de Brito EM, Vasconcelos SMM (2008) Activities of the antipsychotic drugs haloperidol and risperidone on behavioural effects induced by ketamine in mice. Sci Pharm 76(4):673–687CrossRef
go back to reference Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26(7–8):892–904PubMedCrossRef Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 26(7–8):892–904PubMedCrossRef
go back to reference Beaudoin FL, Lin C, Guan W, Merchant RC (2014) Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial. Acad Emerg Med 21(11):1193–1202PubMedCrossRef Beaudoin FL, Lin C, Guan W, Merchant RC (2014) Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial. Acad Emerg Med 21(11):1193–1202PubMedCrossRef
go back to reference Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuro-Psychopharmacol Biol Psychiatry 28:1267–1277CrossRef Becker A, Grecksch G (2004) Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuro-Psychopharmacol Biol Psychiatry 28:1267–1277CrossRef
go back to reference Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de Farias CC, Moreira EG, Barbosa DS (2015) Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis. Schizophr Res 166(1–3):225–230PubMedCrossRef Brinholi FF, Noto C, Maes M, Bonifácio KL, Brietzke E, Ota VK, Gadelha A, Cordeiro Q, Belangero SI, Bressan RA, Vargas HO, Higachi L, de Farias CC, Moreira EG, Barbosa DS (2015) Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug naïve first episode psychosis. Schizophr Res 166(1–3):225–230PubMedCrossRef
go back to reference Canever L, Oliveira L, D'Altoé de Luca R, Correa PT, de B Fraga D, Matos MP, Scaini G, Quevedo J, Streck EL, Zugno AI (2010) A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes. Oxidative Med Cell Longev 3(6):421–427 Canever L, Oliveira L, D'Altoé de Luca R, Correa PT, de B Fraga D, Matos MP, Scaini G, Quevedo J, Streck EL, Zugno AI (2010) A rodent model of schizophrenia reveals increase in creatine kinase activity with associated behavior changes. Oxidative Med Cell Longev 3(6):421–427
go back to reference Cervellati C, Trentini A, Romani A, Bellini T, Bosi C, Ortolani B, Zurlo A, Passaro A, Seripa D, Zuliani G (2015) Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study. J Neurochem 135(2):395–401PubMedCrossRef Cervellati C, Trentini A, Romani A, Bellini T, Bosi C, Ortolani B, Zurlo A, Passaro A, Seripa D, Zuliani G (2015) Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: a pilot study. J Neurochem 135(2):395–401PubMedCrossRef
go back to reference Chang Y, Lee JJ, Hsieh CY, Hsiao G, Chou DS, Sheu JR (2009) Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. Mediat Inflamm 2009:705379CrossRef Chang Y, Lee JJ, Hsieh CY, Hsiao G, Chou DS, Sheu JR (2009) Inhibitory effects of ketamine on lipopolysaccharide-induced microglial activation. Mediat Inflamm 2009:705379CrossRef
go back to reference Cnubben NH, Rietjens IM, Wortelboer H, van Zanden J, van Bladeren PJ (2001) The interplay of glutathione-related processes in antioxidant defense. Environ Toxicol Pharmacol 10(4):141–152PubMedCrossRef Cnubben NH, Rietjens IM, Wortelboer H, van Zanden J, van Bladeren PJ (2001) The interplay of glutathione-related processes in antioxidant defense. Environ Toxicol Pharmacol 10(4):141–152PubMedCrossRef
go back to reference De Luca MT, Meringolo M, Spagnolo PA, Badiani A (2012) The role of setting for ketamine abuse: clinical and preclinical evidence. Rev Neurosci 23(5–6):769–780PubMed De Luca MT, Meringolo M, Spagnolo PA, Badiani A (2012) The role of setting for ketamine abuse: clinical and preclinical evidence. Rev Neurosci 23(5–6):769–780PubMed
go back to reference Devanarayanan S, Nandeesha H, Kattimani S, Sarkar S (2016) Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study. Clin Chem Lab Med 54(3):447–452PubMedCrossRef Devanarayanan S, Nandeesha H, Kattimani S, Sarkar S (2016) Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study. Clin Chem Lab Med 54(3):447–452PubMedCrossRef
go back to reference File SE (1997) Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58(3):747–752PubMedCrossRef File SE (1997) Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58(3):747–752PubMedCrossRef
go back to reference Gutteridge JMC (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinc Chem 41:1819–1828CrossRef Gutteridge JMC (1995) Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clinc Chem 41:1819–1828CrossRef
go back to reference Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685–716PubMedCrossRef Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685–716PubMedCrossRef
go back to reference Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658PubMedCrossRef Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634–1658PubMedCrossRef
go back to reference Hetzler BE, Wautlet BS (1985) Ketamine-induced locomotion in rats in an open-field. Pharmacol Biochem Behav 22(4):653–655PubMedCrossRef Hetzler BE, Wautlet BS (1985) Ketamine-induced locomotion in rats in an open-field. Pharmacol Biochem Behav 22(4):653–655PubMedCrossRef
go back to reference Heurteaux C, Bertaina V, Widmann C, Lazdunski M (1993) K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A 90(20):9431–9435PubMedPubMedCentralCrossRef Heurteaux C, Bertaina V, Widmann C, Lazdunski M (1993) K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. Proc Natl Acad Sci U S A 90(20):9431–9435PubMedPubMedCentralCrossRef
go back to reference Higashino K, Takahashi Y, Yamamura Y (1972) Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride. Clin Chim Acta 41:313–320PubMedCrossRef Higashino K, Takahashi Y, Yamamura Y (1972) Release of phenyl acetate esterase from liver microsomes by carbon tetrachloride. Clin Chim Acta 41:313–320PubMedCrossRef
go back to reference Hou Y, Zhang H, Xie G, Cao X, Zhao Y, Liu Y, Mao Z, Yang J, Wu C (2013) Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 45:107–116CrossRef Hou Y, Zhang H, Xie G, Cao X, Zhao Y, Liu Y, Mao Z, Yang J, Wu C (2013) Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice. Prog Neuro-Psychopharmacol Biol Psychiatry 45:107–116CrossRef
go back to reference Huang K, Gu Y, Hu Y, Ji Z, Wang S, Lin Z, Li X, Xie Z, Pan S (2015) Glibenclamide improves survival and neurologic outcome after cardiac arrest in rats. Crit Care Med 43(9):e341–e349PubMedCrossRef Huang K, Gu Y, Hu Y, Ji Z, Wang S, Lin Z, Li X, Xie Z, Pan S (2015) Glibenclamide improves survival and neurologic outcome after cardiac arrest in rats. Crit Care Med 43(9):e341–e349PubMedCrossRef
go back to reference Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H (2009) Paraoxonase 1 activity in different types of multiple sclerosis. Mult Scler 15:399–402PubMedCrossRef Jamroz-Wisniewska A, Beltowski J, Stelmasiak Z, Bartosik-Psujek H (2009) Paraoxonase 1 activity in different types of multiple sclerosis. Mult Scler 15:399–402PubMedCrossRef
go back to reference Ji MH, Yang JJ, Ju LS, Zhu SH, Yang JJ (2014) Glibenclamide pretreatment attenuates acute lung injury by inhibiting the inflammatory responses and oxidative stress in a polymicrobial sepsis animal model. J Anesthesia and Perioper Med 1:36–43CrossRef Ji MH, Yang JJ, Ju LS, Zhu SH, Yang JJ (2014) Glibenclamide pretreatment attenuates acute lung injury by inhibiting the inflammatory responses and oxidative stress in a polymicrobial sepsis animal model. J Anesthesia and Perioper Med 1:36–43CrossRef
go back to reference Kalueff AV, Tuohimaa P (2005) The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods 143(2):169–177PubMedCrossRef Kalueff AV, Tuohimaa P (2005) The grooming analysis algorithm discriminates between different levels of anxiety in rats: potential utility for neurobehavioural stress research. J Neurosci Methods 143(2):169–177PubMedCrossRef
go back to reference Koga M, Serritella AV, Sawa A, Sedlak TW (2016) Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res 176(1):52–71PubMedCrossRef Koga M, Serritella AV, Sawa A, Sedlak TW (2016) Implications for reactive oxygen species in schizophrenia pathogenesis. Schizophr Res 176(1):52–71PubMedCrossRef
go back to reference Kong JJ, Zhang DD, Li P, Wei CY, Yu HJ, Zhang H, Zhang W, Wang YF, Cao YP (2015) Nicorandil inhibits oxidative stress and amyloid-β precursor protein processing in SH-SY5Y cells overexpressing APPsw. Int J Clin Exp Med 8(2):1966–1975PubMedPubMedCentral Kong JJ, Zhang DD, Li P, Wei CY, Yu HJ, Zhang H, Zhang W, Wang YF, Cao YP (2015) Nicorandil inhibits oxidative stress and amyloid-β precursor protein processing in SH-SY5Y cells overexpressing APPsw. Int J Clin Exp Med 8(2):1966–1975PubMedPubMedCentral
go back to reference Lahmann C, Kramer HB, Ashcroft FM (2015) Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS One 10(7):e0134476PubMedPubMedCentralCrossRef Lahmann C, Kramer HB, Ashcroft FM (2015) Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents. PLoS One 10(7):e0134476PubMedPubMedCentralCrossRef
go back to reference Lee EE, Eyler LT, Wolkowitz OM, Martin AS, Reuter C, Kraemer H, Jeste DV (2016) Elevated plasma F2-isoprostane levels in schizophrenia. Schizophr Res 176(2–3):320–326PubMedPubMedCentralCrossRef Lee EE, Eyler LT, Wolkowitz OM, Martin AS, Reuter C, Kraemer H, Jeste DV (2016) Elevated plasma F2-isoprostane levels in schizophrenia. Schizophr Res 176(2–3):320–326PubMedPubMedCentralCrossRef
go back to reference Mion G, Villevieille T (2013) Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 19(6):370–380PubMedPubMedCentralCrossRef Mion G, Villevieille T (2013) Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther 19(6):370–380PubMedPubMedCentralCrossRef
go back to reference Monte AS, de Souza GC, McIntyre RS, Soczynska JK, dos Santos JV, Cordeiro RC, Ribeiro BM, de Lucena DF, Vasconcelos SM, de Sousa FC, Carvalho AF, Macêdo DS (2013) Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol 27(11):1032–1043PubMedCrossRef Monte AS, de Souza GC, McIntyre RS, Soczynska JK, dos Santos JV, Cordeiro RC, Ribeiro BM, de Lucena DF, Vasconcelos SM, de Sousa FC, Carvalho AF, Macêdo DS (2013) Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathways. J Psychopharmacol 27(11):1032–1043PubMedCrossRef
go back to reference Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41:892–896PubMedCrossRef Moshage H, Kok B, Huizenga JR, Jansen PL (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41:892–896PubMedCrossRef
go back to reference Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128(3):419–432PubMedCrossRef Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK (2010) Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism. Pharmacol Ther 128(3):419–432PubMedCrossRef
go back to reference Nguyen SD, Sok DE (2003) Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 37(12):1319–1330PubMedCrossRef Nguyen SD, Sok DE (2003) Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res 37(12):1319–1330PubMedCrossRef
go back to reference de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG, Dal-Pizzol F, Quevedo J, Zugno AI (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuro-Psychopharmacol Biol Psychiatry 33(6):1003–1008CrossRef de Oliveira L, Spiazzi CM, Bortolin T, Canever L, Petronilho F, Mina FG, Dal-Pizzol F, Quevedo J, Zugno AI (2009) Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuro-Psychopharmacol Biol Psychiatry 33(6):1003–1008CrossRef
go back to reference Ortega FJ, Jolkkonen J, Mahy N, Rodríguez MJ (2013) Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab 33(3):356–364PubMedCrossRef Ortega FJ, Jolkkonen J, Mahy N, Rodríguez MJ (2013) Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab 33(3):356–364PubMedCrossRef
go back to reference Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, McKenna PJ, Bullmore ET, Fletcher PC (2006) Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry 189:173–179PubMedCrossRef Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, McKenna PJ, Bullmore ET, Fletcher PC (2006) Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry 189:173–179PubMedCrossRef
go back to reference Powers AR 3rd, Gancsos MG, Finn ES, Morgan PT, Corlett PR (2015) Ketamine-induced hallucinations. Psychopathology 48(6):376–385PubMedCrossRef Powers AR 3rd, Gancsos MG, Finn ES, Morgan PT, Corlett PR (2015) Ketamine-induced hallucinations. Psychopathology 48(6):376–385PubMedCrossRef
go back to reference Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33PubMedCrossRef Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33PubMedCrossRef
go back to reference Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A (2011) Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry 11:124PubMedPubMedCentralCrossRef Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A (2011) Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry 11:124PubMedPubMedCentralCrossRef
go back to reference Rao VS, Carvalho AC, Trevisan MTS, Andrade GM, Júnior HVN, Moraes MO, Iury HIMH, Morais TC, Santos FA (2012) Mangiferin ameliorates 6-hydroxydopamine induced cytotoxicity and oxidative stress in ketamine model of schizophrenia. Pharmacol Rep 64:848–856PubMedCrossRef Rao VS, Carvalho AC, Trevisan MTS, Andrade GM, Júnior HVN, Moraes MO, Iury HIMH, Morais TC, Santos FA (2012) Mangiferin ameliorates 6-hydroxydopamine induced cytotoxicity and oxidative stress in ketamine model of schizophrenia. Pharmacol Rep 64:848–856PubMedCrossRef
go back to reference Roth KA, Katz RJ (1979) Stress, behavioral arousal, and open field activity—a reexamination of emotionality in the rat. Neurosci Biobehav Rev 3:247–263PubMedCrossRef Roth KA, Katz RJ (1979) Stress, behavioral arousal, and open field activity—a reexamination of emotionality in the rat. Neurosci Biobehav Rev 3:247–263PubMedCrossRef
go back to reference Rubaiy HN (2016) The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharma 66:23–34CrossRef Rubaiy HN (2016) The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharma 66:23–34CrossRef
go back to reference Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383–388PubMedCrossRef Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59:383–388PubMedCrossRef
go back to reference Sahara M, Sata M, Morita T, Hirata Y, Nagai R (2012) Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension. PLoS One 7(3):e33367PubMedPubMedCentralCrossRef Sahara M, Sata M, Morita T, Hirata Y, Nagai R (2012) Nicorandil attenuates monocrotaline-induced vascular endothelial damage and pulmonary arterial hypertension. PLoS One 7(3):e33367PubMedPubMedCentralCrossRef
go back to reference Sarandol A, Sarandol E, Acikgoz HE, Eker SS, Akkaya C, Dirican M (2015) First-episode psychosis is associated with oxidative stress: effects of short-term antipsychotic treatment. Psychiatry Clin Neurosci 69(11):699–707PubMedCrossRef Sarandol A, Sarandol E, Acikgoz HE, Eker SS, Akkaya C, Dirican M (2015) First-episode psychosis is associated with oxidative stress: effects of short-term antipsychotic treatment. Psychiatry Clin Neurosci 69(11):699–707PubMedCrossRef
go back to reference Sato T, Sasaki N, O’Rourke B, Marban E (2000) Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35:514–518PubMedCrossRef Sato T, Sasaki N, O’Rourke B, Marban E (2000) Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35:514–518PubMedCrossRef
go back to reference Shimizu S, Oikawa R, Tsounapi P, Inoue K, Shimizu T, Tanaka K, Martin DT, Honda M, Sejima T, Tomita S, Saito M (2014) Blocking of the ATP sensitive potassium channel ameliorates the ischaemia-reperfusion injury in the rat testis. Andrology 2:458–465PubMedCrossRef Shimizu S, Oikawa R, Tsounapi P, Inoue K, Shimizu T, Tanaka K, Martin DT, Honda M, Sejima T, Tomita S, Saito M (2014) Blocking of the ATP sensitive potassium channel ameliorates the ischaemia-reperfusion injury in the rat testis. Andrology 2:458–465PubMedCrossRef
go back to reference Silvestre JS, Nadal R, Pallarés M, Ferré N (1997) Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5(1):29–33PubMedCrossRef Silvestre JS, Nadal R, Pallarés M, Ferré N (1997) Acute effects of ketamine in the holeboard, the elevated-plus maze, and the social interaction test in Wistar rats. Depress Anxiety 5(1):29–33PubMedCrossRef
go back to reference Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V (2009) Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma 26(12):2257–2267PubMedPubMedCentralCrossRef Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V (2009) Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma 26(12):2257–2267PubMedPubMedCentralCrossRef
go back to reference Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ (2015) Oxytocin reduces amygdala activity, increases social interactions and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav Neurosci 129(4):389–398PubMedPubMedCentralCrossRef Sobota R, Mihara T, Forrest A, Featherstone RE, Siegel SJ (2015) Oxytocin reduces amygdala activity, increases social interactions and reduces anxiety-like behavior irrespective of NMDAR antagonism. Behav Neurosci 129(4):389–398PubMedPubMedCentralCrossRef
go back to reference Sun HS, Feng ZP (2013) Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia. Acta Pharmacol Sin 34:24–32PubMedCrossRef Sun HS, Feng ZP (2013) Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia. Acta Pharmacol Sin 34:24–32PubMedCrossRef
go back to reference Taira N (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J–24JPubMedCrossRef Taira N (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J–24JPubMedCrossRef
go back to reference Teshima Y, Akao M, Li RA, Chong TH, Baumgartner WA, Johnston MV, Marbán E (2003) Mitochondrial ATP-sensitive potassium channel activation protects cerebellar granule neurons from apoptosis induced by oxidative stress. Stroke 34:1796–1802PubMedCrossRef Teshima Y, Akao M, Li RA, Chong TH, Baumgartner WA, Johnston MV, Marbán E (2003) Mitochondrial ATP-sensitive potassium channel activation protects cerebellar granule neurons from apoptosis induced by oxidative stress. Stroke 34:1796–1802PubMedCrossRef
go back to reference Wilson CA, Koenig JI (2014) Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24(5):759–773PubMedCrossRef Wilson CA, Koenig JI (2014) Social interaction and social withdrawal in rodents as readouts for investigating the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24(5):759–773PubMedCrossRef
go back to reference Xie J, Duan L, Qian X, Huang X, Ding J, Hu G (2010) K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. J Neurosci Res 88(2):428–437PubMedCrossRef Xie J, Duan L, Qian X, Huang X, Ding J, Hu G (2010) K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production. J Neurosci Res 88(2):428–437PubMedCrossRef
go back to reference Yamada K, Inagaki N (2002) ATP-sensitive K+ channels in the brain: sensors of hypoxic conditions. News Physiol Sci 17:127–130PubMed Yamada K, Inagaki N (2002) ATP-sensitive K+ channels in the brain: sensors of hypoxic conditions. News Physiol Sci 17:127–130PubMed
go back to reference Young J, McKinney SB, Ross BM, Wahle KW, Boyle SP (2007) Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 76(2):73–85.0PubMedCrossRef Young J, McKinney SB, Ross BM, Wahle KW, Boyle SP (2007) Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 76(2):73–85.0PubMedCrossRef
go back to reference Zhang X, Feng J, Zhu P, Zhao Z (2013) Ketamine inhibits calcium elevation and hydroxyl radical and nitric oxide production in lipopolysaccharide-stimulated NR8383 alveolar macrophages. Inflammation 36(5):1094–1100PubMedCrossRef Zhang X, Feng J, Zhu P, Zhao Z (2013) Ketamine inhibits calcium elevation and hydroxyl radical and nitric oxide production in lipopolysaccharide-stimulated NR8383 alveolar macrophages. Inflammation 36(5):1094–1100PubMedCrossRef
Metadata
Title
Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice
Authors
Omar M. E. Abdel-Salam
Marwa El-Sayed El-Shamarka
Publication date
01-07-2017
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 4/2017
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-017-2471-x

Other articles of this Issue 4/2017

Comparative Clinical Pathology 4/2017 Go to the issue